Menu:
Calcium Ascorbate
Blogs about Calcium Ascorbate
- Jarrow Buffered Vitamin C Calcium Ascorbate, 100 tabs »
Jarrow Buffered Vitamin C Calcium Ascorbate, 100 tabs Calcium ascorbate is Vitamin C fully reacted to calcium, providing a buffered, nonacidic form of ascorbic acid. Vitamin C is essential for the maintenance of connective tissue, ...
- Bone Support Targeted MultiNutrition Supplement Kit Comprehensive ... »
BUFFERED C NonAcidic Calcium Ascorbate 500 mg Efficiently Digested Calcium Ascorbate Calcium Ascorbate is a nonacidic form of Vitamin C and provides the additional benefits of Calcium. This formulation ...
- 820mg 3 lbs. Powder) »
820mg 3 lbs. Powder) Ascorbic Acid is another name for Vitamin C.Vitamin C is a popular antioxidant and one of the most widely used vitamins in the world.Fine Ascorbic acid is a bioavailable form of ...
- Now Foods C500 Ascorbate Caps 250 caps »
Antioxidant Protection Calcium AscorbateC Buffered, NonAcidic With Bioflavonoids Vitamin C is perhaps the most popular vitamin known to man. It is consumed in a supplemental form by millions of people across the world for its ...
- Calcium Ascorbate Vitamin C Powder 3 lb, NOW Foods »
Calcium Ascorbate is an optimal nutritional supplement that combines Ascorbic Acid (Vitamin C) with Calcium Carbonate. By combining these two dietary ingredients, we have created a buffered source of Vitamin C that will not contribute ...
- Oral Brand Drug »
Oral Brand DrugIMPORTANT NOTE: the following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. ...
Selected News
Salix Pharmaceuticals Announces 1Q2008 Financial Results Conference Call and Web Cast (Centre Daily Times)
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report first quarter ended March 31, 2008 financial results following the close of the U.S. financial markets on Tuesday, May 6, 2008. Read more
Salix Receives Purported Notice of Paragraph IV Certification Against Patent for MOVIPREP(R) (Business Wire via Yahoo Finance)
RALEIGH, N.C.Salix Pharmaceuticals, Ltd. today announced that the Company and its licensor, Norgine B.V., have received a purported notice of Paragraph IV Certification on behalf of Novel Laboratories, Inc. advising of the submission of an Abbreviated New Drug Application for MOVIPREP . Read more